BIOLOGIC TOLERANCE OF 2 DIFFERENT LOW-MOLECULAR-WEIGHT HEPARINS

被引:24
|
作者
CHRISTIANSEN, HM [1 ]
LASSEN, MR [1 ]
BORRIS, LC [1 ]
SORENSEN, JV [1 ]
RAHR, HB [1 ]
JORGENSEN, LN [1 ]
JORGENSEN, PW [1 ]
HAUCH, O [1 ]
机构
[1] AARHUS KOMMUNE HOSP,DK-8000 AARHUS,DENMARK
来源
SEMINARS IN THROMBOSIS AND HEMOSTASIS | 1991年 / 17卷 / 04期
关键词
D O I
10.1055/s-2007-1002654
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:450 / 454
页数:5
相关论文
共 50 条
  • [31] Therapeutic equivalency of low-molecular-weight heparins
    McCart, GM
    Kayser, SR
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (06) : 1042 - 1057
  • [32] Prescribing Errors With Low-Molecular-Weight Heparins
    Slikkerveer, Marielle
    van de Plas, Afke
    Driessen, Johanna H. M.
    Wijngaard, Robin
    de Vries, Frank
    Olie, Renske
    Meertens, Nathalie
    van den Bemt, Patricia
    JOURNAL OF PATIENT SAFETY, 2021, 17 (07) : E587 - E592
  • [33] Low-molecular-weight heparins in clinical practice
    Hunt, D
    SOUTHERN MEDICAL JOURNAL, 1998, 91 (01) : 2 - 10
  • [34] PHARMACOKINETICS OF HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARINS
    AMBROSIONI, E
    STROCCHI, E
    HAEMOSTASIS, 1990, 20 : 94 - 97
  • [35] LOW-MOLECULAR-WEIGHT HEPARINS - IS SMALLER BETTER
    TRIPLETT, DA
    ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (13) : 1525 - 1526
  • [36] Low-molecular-weight heparins and heparinolds - In reply
    Eikelboom, JW
    Hankey, GJ
    MEDICAL JOURNAL OF AUSTRALIA, 2003, 178 (08) : 414 - 415
  • [37] HYPOALDOSTERONISM INDUCED BY LOW-MOLECULAR-WEIGHT HEPARINS
    LEVESQUE, H
    CAILLEUX, N
    NOBLET, C
    GANCEL, A
    MOORE, N
    COURTOIS, H
    PRESSE MEDICALE, 1991, 20 (01): : 35 - 35
  • [38] Clinical uses for low-molecular-weight heparins
    Wise, GR
    WESTERN JOURNAL OF MEDICINE, 1996, 164 (05): : 440 - 440
  • [39] POSSIBLE BENEFITS OF LOW-MOLECULAR-WEIGHT HEPARINS
    BREIMER, L
    BRITISH MEDICAL JOURNAL, 1994, 309 (6960): : 1019 - 1019
  • [40] LOW-MOLECULAR-WEIGHT HEPARINS - AN OBJECTIVE OVERVIEW
    HOPPENSTEADT, D
    WALENGA, JM
    FAREED, J
    DRUGS & AGING, 1992, 2 (05) : 406 - 422